S-588210
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for S-588210, covering 2018-05-14 to 2018-05-14. Get the full timeline:
Most recent: Clinical Trial Update: A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy [Phase 1]